Texas § 2177.001 DEFINITIONS.

Texas Statutes

§ 2177.001 — DEFINITIONS.

Texas § 2177.001

Code GVGovernment Code

This text of Texas § 2177.001 (DEFINITIONS.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Government Code Code Ann. § 2177.001 (2026).

Text

Sec. 2177.001. DEFINITIONS. In this chapter:

(1)"Advisory council" means the Texas Pharmaceutical Initiative Advisory Council established under this chapter.

(2)"Board" means the governing board of the initiative.

(3)"Commission" means the Health and Human Services Commission.

(4)"Generic biological product" means a biological product approved pursuant to an application under Section 351(k), Public Health Service Act (42 U.S.C. Section 262(k)).

(5)"Generic drug" means a prescription drug approved pursuant to an application under Section 505(j), Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 355(j)).

(6)"Initiative" means the Texas Pharmaceutical Initiative established under this chapter.

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 2177.001. DEFINITIONS. In this chapter:
(1) "Advisory council" means the Texas Pharmaceutical Initiative Advisory Council established under this chapter.
(2) "Board" means the governing board of the initiative.
(3) "Commission" means the Health and Human Services Commission.
(4) "Generic biological product" means a biological product approved pursuant to an application under Section 351(k), Public Health Service Act (42 U.S.C. Section 262(k)).
(5) "Generic drug" means a prescription drug approved pursuant to an application under Section 505(j), Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 355(j)).
(6) "Initiative" means the Texas Pharmaceutical Initiative established under this chapter.